Profile
Lee Swem formerly worked at Achaogen, Inc., as Chief Scientific Officer from 2017 to 2018.
Dr. Swem received his doctorate degree from Indiana University.
Former positions of Lee Swem
Companies | Position | End |
---|---|---|
ACHAOGEN | Chief Tech/Sci/R&D Officer | 24/09/2018 |
Training of Lee Swem
Indiana University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Lee Swem